J Comp Eff Res · 2023
Comparative efficacy and safety among high-intensity statins. Systematic Review and Meta-AnalysisConclusion: Conclusion: This review further confirms that high-intensity statins reduce LDL by ≥50%, favoring rosuvastatin over atorvastatin. Additional data are needed to confirm the clinical significance on cardiovascular outcomes using real-world studies.